Stay updated with breaking news from Purple Book. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Original biologic products, and more recently biosimilar products, are a groundbreaking advancement in modern medical treatments. Pharmacists should understand biologic products and concerns with biosimilars.
News analysis, case studies and informed comment on the challenges facing UK pension schemes, from Pensions Expert, a DG Publishing service
In this Policy Forum piece, Robin Feldman discusses how current legislation contributes to informational deficits around drug patents for biologic drugs in the United States.
11. COVID-19 and Life Sciences</strong>, the US government has used a wide variety of public procurement and funding strategies for needed medical countermeasures during the pandemic.
In this review, we discuss the most important recent developments in the biosimilars space, including new biosimilar approvals and launches, litigation under the Biologics Price...